HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Joachim Weipert Christian Schreiber Martin Kostolny Ruediger Lange Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Weipert, J. Articles by Lange, R. Search for Related Content PubMed PubMed Citation Articles by Weipert, J. Articles by Lange, R. Related Collections Electrophysiology - arrhythmias

J Thorac Cardiovasc Surg 2004;127:457-464
© 2004 The American Association for Thoracic Surgery

Surgery for congenital heart disease

Occurrence and management of atrial arrhythmia after long-term Fontan circulation

^a Department of Cardiac Surgery, German Heart Center Munich, Technical University Munich, Munich, Germany
^b Department of Cardiology, German Heart Center Munich, Technical University Munich, Munich, Germany,
^c Department of Pediatric Cardiology and Congenital Heart Disease, German Heart Center Munich, Technical University Munich, Munich, Germany

Read at the Eighty-third Annual Meeting of The American Association for Thoracic Surgery, Boston, Mass, May 4-7, 2003.

Received for publication May 2, 2003; revisions received July 31, 2003; accepted for publication August 11, 2003.

^* Address for reprints: Joachim Weipert, MD, Department of Cardiac Surgery, German Heart Center Munich, Lazarettstr. 36, 80636 Munich, Germany
Weipert{at}dhm.mhn.de

	Abstract

Top Abstract Methods Results Discussion References

 
OBJECTIVES: In patients after the Fontan operation, we determined risk factors for late failure and for intra-atrial re-entrant tachycardia at 15 to 20 years' follow-up. Midterm results after electrophysiologic ablation therapy for these tachycardias were also evaluated.

METHODS: Current follow-up was available in 162 patients (2005 patient-years) with a wide range of underlying diagnoses operated on between February 1978 and May 1995. Risk factor analysis included patient-related and procedure-related variables, with late failure and the incidence of re-entrant tachycardia as outcome parameters.

RESULTS: Forty late failures were observed (2.0 per 100 patient-years). At 15 years, Kaplan-Meier estimated survival was significantly (P = .007) better for patients with tricuspid atresia (93%) compared with that for patients with complex congenital malformation (71%). The sole multivariable risk factor for Fontan failure was the type of underlying diagnosis. At 20 years' follow-up, overall freedom from tachycardia was estimated to be 46% ± 12%. Acute success of electrophysiologic ablation was seen in 25 (83%) of 30 patients, and Kaplan-Meier estimated freedom from recurrent tachycardia was 81% ± 10% at 3 years. Multivariate analysis identified duration of Fontan circulation as the sole risk factor for re-entrant tachycardias.

CONCLUSION: After the modified Fontan operation, long-term survival in patients with tricuspid atresia was significantly better compared with that in patients with complex congenital malformations. As first-choice therapy for atrial re-entrant tachycardias, we recommend electrophysiologic ablation therapy.

The purpose of this article is to document our results with radiofrequency ablation therapy of tachycardia in patients after the Fontan operation. We determined patient- and procedure-related risk factors influencing late Fontan failure, development of IARTs, and management strategy.

	Methods

Top Abstract Methods Results Discussion References

 
Patient population
Patients undergoing modifications of the Fontan procedure at the German Heart Centre Munich operated on between February 1978 and May 1995 were studied. The indication for the modified Fontan operation was given when a significant increase of cyanosis, reduction of physical capabilities, or both was observed. In each patient preinterventional and postinterventional data were extracted by means of review of the medical records or personal contact. Preoperative cardiac catheterization data were available for all patients and, in conjunction with echocardiographic data, served as the basis for assessment of atrial and ventricular morphology and hemodynamic data. The actual clinical condition was verified in the outpatient pediatric cardiology department. To facilitate data analysis on the basis of the morphology of the underlying congenital heart disease, we assigned the patients either to a tricuspid atresia (TrA) group or to a complex congenital malformation (CCM) group, who were not amenable for 2-ventricle repair. Patients with a hypoplastic left heart syndrome were not referred for surgical therapy at that time. Also, patients were assigned to the type of Fontan pathway: either right atrial to right ventricle (RA-RV) or right atrial to pulmonary artery (RA-PA) types of Fontan procedures. During that time, the RA-PA connection was either a direct RA-PA anastomosis, or the connection was performed with allografts or with a lateral tunnel of autologous atrial tissue. Prosthetic material, as used in recent modifications for total cavopulmonary connections, was not used.

Electrophysiologic technique
If patients had been treated unsuccessfully with an average of 3 antiarrhythmic drugs, an ablation procedure was indicated. Antiarrhythmic drugs were discontinued more than 5 plasma half-lives before the study. For the procedure, patients were sedated with midazolam (1-2 mg administered intravenously). A 64-electrode basket catheter (Constellation; EP Technologies, San Jose, Calif), providing 56 bipolar electrocardiograms, was placed in the right atrium through an 11F-long sheath inserted from the femoral or internal jugular veins. On the basis of echocardiographic estimation of right atrial dimensions, basket diameters between 48 and 90 mm were used.^15,16 After basket catheter deployment, a 5F decapolar catheter with an interelectrode distance of 2 to 10 mm spacing between electrodes was positioned in the coronary sinus (in cases when the coronary sinus was not surgically drained in the left atrium) to detect small changes in intracardiac position. The third catheter was used as a roving catheter to record and pace from selected sites in the right atrium and to perform radiofrequency ablation.

Definitions
Fontan survivors were defined as patients with an intact Fontan pathway of any modification. Fontan failure was defined as death at the time of last follow-up because during late follow-up, no takedown of the Fontan circulation to a systemic to pulmonary shunt procedure was performed. Time to IART was defined as the period beginning 30 days after the Fontan procedure and extending to the date of the first electrophysiologic investigation. By defining time to IART in this way, the uncertain effects of early arrhythmias in patients without frequent follow-up were eliminated. Patients with antiarrhythmic drugs and regular sinus rhythm were censored at the time of the most recent follow-up.

Statistical analysis
Overall late Fontan failure and the incidence of postoperative IARTs served as outcome parameters. The influence of early mortality was eliminated by defining survival time as the period beginning 30 days after the Fontan procedure. Patients in whom the Fontan circulation did not fail were censored at the time of last follow-up. Estimated actuarial survival and freedom from IARTs were determined by using the Kaplan-Meier method. Significance during univariable analysis was assessed by using the log-rank test when the type of diagnosis for Fontan survival and the type of Fontan anastomosis for IART were the outcome parameters during the Kaplan-Meier procedure. For multivariable analysis, the Cox proportional-hazards regression model was used to establish the variables independently predictive of Fontan failure and the incidence of IARTs. Hazard ratios with 95% confidence intervals were constructed for the significant multivariable predictors. Final models were derived by using the forward stepwise selection procedure. Variables having P value of less than .1 in the univariable analyses were entered as candidates into the Cox regression models. A P value of less than .05 was required for the variable to be retained in the equation. All reported P values are 2 tailed. Statistical analysis was performed with the SPSS software package (version 10.1; SPSS, Inc, Chicago, Ill). Data are presented as means ± SEM or SD as indicated.

	Results

Top Abstract Methods Results Discussion References

 
Patient characteristics
A total of 182 modified Fontan procedures have been performed during the study period, and 162 long-term survivors (2005 patient-years) were included in the study. Eighty-four patients were male, and 78 were female. In 92 patients the diagnosis of TrA was the leading cardiac malformation. Seventy patients with a wide range of underlying cardiac malformations were summarized as having CCMs. Forty-five patients had no palliative procedures before the Fontan operation. One hundred seventeen patients had previously undergone a total of 160 palliative procedures: 63 patients had at least one systemic to pulmonary artery shunt, 43 patients had pulmonary artery banding, 5 patients had coarctation repair, 1 patient had a bidirectional Glenn procedure, and 5 patients had comissurotomy of the pulmonary valve. Age at first palliation was not significantly (P = .255) different for patients with TrA and CCMs, being 2.4 ± 3.5 years (median, 0.75 years) and 1.8 ± 2.4 years (median, 0.8 years), respectively. From the total of 162 patients, 40 late Fontan failures occurred (1.99 per 100 patient-years).

For RA-RV anastomoses, either the Bjoerk¹⁷ modification (n = 60) with a polytetrafluoroethylene^* tunnel or an allograft (n = 10) was used. For RA-PA connection, either a direct right atrial to pulmonary artery anastomosis (n = 26)¹⁸ or allografts (n = 14) or a lateral tunnel constructed with autologous atrial tissue (n = 52) was used. Between patients with Fontan failure and survivors, no significant difference for preoperative mean pulmonary artery pressure, mean indexed pulmonary artery resistance, mean right atrial pressure, mean ventricular end-diastolic pressure, and mean hematocrit and hemoglobin values was found (Table 1). Preoperatively, 154 (95.1%) patients were in sinus rhythm, and 4 patients showed atrial fibrillation or intermittent tachycardias that could be controlled by medical therapy. In 2 patients pacemakers for treatment of bradyarrhythmia were implanted. The mean age at the time of the Fontan operation was significantly (P = .04) different, being 7.8 ± 5.9 (SD) years (median, 6.1 years) for patients with TrA and 9.7 ± 5.6 years (median, 7.8 years) for patients with CCMs. The mean Fontan circulation time was significantly (P = .002) longer for patients with TrA (13.5 ± 4.8 years; median, 13.9 years) compared with that for patients with CCMs (10.9 ± 5.3 years; median, 12.4 years). The Kaplan-Meier estimate of overall freedom from Fontan failure was 89.0% ± 2.4%, 83.0% ± 3.8%, 77.0% ± 3.5%, and 59.0% ± 7.7% at 5, 10, 15, and 20 years' follow-up (Figure 1). The Kaplan-Meier estimate of freedom from Fontan failure at 15 years was significantly (P = .007, log-rank test) higher for patients with TrA (83.0% ± 4.0%) compared with that for patients with CCMs (70.8% ± 5.5%). In 17 (11%) patients conversion of the modified Fontan pathway to total cavopulmonary connection was performed during follow-up.

View larger version (12K): [in this window] [in a new window]   Figure 1. Kaplan-Meier estimates of the probability of late survival with a Fontan circulation. Time zero is 30 days after the Fontan operation. Numbers of patients at risk are shown in parentheses.

View larger version (12K): [in this window] [in a new window]   Figure 2. Kaplan-Meier estimates of the probability of freedom from atrial flutter. Time zero is 30 days after the Fontan operation. Numbers of patients at risk are shown in parentheses.

View larger version (12K): [in this window] [in a new window]   Figure 3. Kaplan-Meier estimates of the probability of freedom from atrial flutter as a function of the type of Fontan operation: RA-PA, right atrial to pulmonary artery (solid line); RA-RV, right atrial to right ventricle (dashed line). Time zero is 30 days after the Fontan operation. Numbers of patients at risk are shown in parentheses. The type of Fontan operation was significantly (P = .05, log-rank test) different for patients in whom atrial flutter developed.

View larger version (17K): [in this window] [in a new window]   Figure 4. Kaplan-Meier estimates of the probability of freedom from atrial flutter as a function of time after the electrophysiologic ablation procedure in patients with immediate successful termination of the re-entrant tachycardia. Time zero indicates after the intervention. Numbers of patients at risk are shown in parentheses.

	Discussion

Top Abstract Methods Results Discussion References

Risk factors for late Fontan failure
The surgical procedures used in this Fontan series resulted in a functional status that was found to be comparable with data reported in the literature.¹⁹ Four large series^1,2,8,20 have provided important information about late outcome after the modified Fontan operation. Yet comparison of outcome measures between institutions is not possible without fully accounting for patient selection, surgical modifications, time of operation, interventional catheter techniques, and postoperative management. Nevertheless, Kaplan-Meier estimates of late Fontan failure in our series (eg, at 15 years being 77.0% ± 3.5%) are comparable with those published in the above-mentioned series. Multivariate Cox proportional hazard testing showed the diagnosis of CCM as significantly associated with Fontan failure. These data indicate that patient-related but not procedure-related variables determine the outcome in patients undergoing the Fontan operation during late follow-up.

Risk factors for IART
The development of tachycardia during the life of a patient who has undergone the Fontan operation has been a matter of concern since the introduction of the Fontan procedure in 1971.²¹ In our Fontan population the development of tachycardia was clearly a time-dependent process (Figure 2). To overcome the uncertainty of the clinical significance of IART after the Fontan operation, we defined the time until the first IART treatment, determined by means of radiofrequency ablation, as an outcome parameter. The Kaplan-Meier estimated freedom from tachycardia is similar to values published from other series.^5,6 In general, patients with an RA-RV anastomosis had a more simple underlying cardiac malformation compared with the patients with RA-PA anastomoses (Figure 3). This might explain why patients with RA-RV connections had a significantly (during univariable analysis) lesser incidence of tachycardia. Yet in the multivariable Cox proportional-hazard model, this difference was lost, and duration of follow-up remained the only significant variable for the development of tachycardia (Table 2). Summarizing the data from this and 2 recent studies^5,6 doing an overview of 995 patients undergoing the Fontan operation, the duration of the follow-up interval,⁵ prior palliation with atrial septectomy,⁵ and atrioventricular valve replacement⁶ remain independent risk factors for the development of atrial tachycardia after the modified Fontan operation.

Management for IART
In patients undergoing the Fontan operation, the critical isthmus for the re-entrant circuit in atrial flutter was located between the tricuspid annulus, the coronary sinus, and the Eustachian ridge adjacent to the inferior vena cava.²² This region was also involved in the majority of our patients. In addition, further zones of slow conduction that define a critical isthmus in which radiofrequency ablation is likely to be successful have been identified and were also targeted: between the atriotomy and (1) the tricuspid annulus or the (2) superior or (3) inferior vena cava or (4) between the tricuspid annulus and the Fontan conduit. We performed an electroanatomic mapping technique for identification of the critical tachycardia zone, of which a detailed description has been recently published.²³ This technique offers at least 3 advantages for mapping and guiding ablation of IARTs after the Fontan operation: (1) acquisition of multiple and simultaneous recordings; (2) software-assisted activation maps that rapidly identify zones of split potentials and slow conduction that can be further analyzed with an entrainment technique as possible targets for radiofrequency ablation; and (3) multiple and stable rows of electrodes representing a reliable tool to verify the completeness of the ablation lines.

Early and high recurrence rates of tachycardia after electrophysiologic ablation therapy have been reported in a small series of patients undergoing the Fontan operation.¹⁰ Therefore right atrial Cox maze procedure, pacemaker insertion, and conversion to total cavopulmonary connection was recommended as first-choice therapy in these patients.^11-13 However, comparison of outcome measures between institutions is not possible for the same reasons mentioned above. Furthermore, innovation of the electrophysiologic technique (eg, introduction of bidirectional pacing to assess lesion continuity and better software) and gaining experience might influence early and late success.^16,23 By using this technique, 80% freedom from IART at 3 years' follow-up or reduction of tachycardia frequency could be achieved. In our experience patients with tachycardia do not frequently have a failing Fontan circulation, which would facilitate indication for conversion to cavopulmonary connection. Therefore our concept is that surgical intervention should be reserved for those patients with failed electrophysiologic ablation or IARTs with failing Fontan circulation.

Limitations of the study
The validity of our study is clearly limited by its retrospective nature and evaluation of data in a nonconsecutive patient group. Although long-term follow-up information was available in a high percentage of the patients, the incidence of IART is most likely underestimated because of the transient nature of some arrhythmias and the limited availability of serial electrocardiographic and Holter studies. Interpretation of the results is also difficult because there is a lack of an unoperated or conventionally palliated patient population as a control group.

Since 1995, we have changed our institutional policy and abandoned the modified Fontan operations described in this series. Recent data from patients with total cavopulmonary anastomoses¹⁴ indicate that the lateral tunnel approach with prosthetic material and early correction of cyanosis considerably reduces the incidence of atrial arrhythmia compared with that of the patient group presented in this article. Thus this article might serve as a basis for future studies, clarifying the long-term outcome and treatment approach for IART in patients with the older Fontan modifications.

Conclusions
In this retrospective study we have shown that late survival after the Fontan operation was significantly determined by the patients' underlying congenital malformations. The long-term survival was estimated to be higher in patients with TrA compared with that in patients with CCM. IART develops over time after the Fontan operation, regardless of the type of underlying morphology. By using 3-dimensional atrial electroanatomic activation mapping, rapid and comprehensive therapy of re-entrant atrial tachyarrhythmias in patients undergoing the Fontan operation is achieved. Surgical intervention should be reserved for those patients who do not respond to interventional therapy.

Discussion
Dr Constantine Mavroudis (Chicago, Ill). Dr Weipert and associates have presented their experience with 162 patients undergoing the Fontan operation with varying types of venoatrial pulmonary artery connections. Congratulations on a very nice presentation. It was clear, succinct, and easy to follow.

Dr Weipert and associates divided their patients into 2 groups, namely the TrA group and the complex group. The incidence of atrial tachycardia over time was documented, and they also showed the benefits of transcatheter ablation in controlling atrial arrhythmias in some 25 patients. Their results are better than most in the literature, but nevertheless, they have a 50% recurrence rate over a 5-year period. This article was nicely presented and serves as an important benchmark because of the significant follow-up, which includes approximately 2000 patient-years.

Our experience at Children's Memorial Hospital in Chicago has centered on those patients who had Fontan failure on the basis of atrial arrhythmias, pathway obstructions, and valvular dysfunction. In your article you thought that it was unlikely that arrhythmias would be the sole cause of Fontan failure. We have a differing opinion in that we have seen a number of patients who have had atrial arrhythmias over long periods of time who have ventricular dysfunction and have regained their ventricular function after the maze procedure. Perhaps you could comment on this issue.

I have several other questions. I see from the article that you excluded patients with hypoplastic left heart syndrome. Is it because you had few patients like this, or have you excluded others with other more complex anatomy, and if you did, can you tell us why?

Also, did you see a difference in the transcatheter ablation success rate between the patients with TrA and your complex congenital patients? The reason I ask this is because the patients with TrA tend to have thicker atrial walls and might not be treatable by means of energy-giving techniques because of the difficulty in creating transmural lesions. You might want to give us some thoughts on that.

And another thing, I did not see in your long follow-up any patients who had atrial fibrillation. Did any of your patients have atrial fibrillation? We contend that atrial fibrillation is the natural course after atrial re-entrant tachycardia for a significant number of these patients; that is to say, the first arrhythmia is atrial re-entrant tachycardia followed in time with atrial fibrillation. If you did have patients like that, did you take these patients to the catheterization laboratory and try to perform a left- and right-sided maze procedure to convert them or did you operate on them?

We do not have a problem with performing transcatheter ablation for our sets of patients. However, we find that a number of these patients have pathway obstructions and anatomic problems as well, and therefore we usually go to surgical intervention with these patients.

I look forward to your comments, and I also look forward to your transcatheter techniques getting better, where these patients hopefully will not have to have an operation that is as large as this one.

Dr Weipert. Thank you very much, Dr Mavroudis. I skipped the problem of conversion operation to total cavopulmonary connection in these patients, but we did 17 conversions in patients with the full symptoms of Fontan disease, such as together with fibrillation, flutter, and protein-losing enteropathy, and there was a mortality rate of about 25%. Therefore we are reluctant to go ahead and do the operation in patients who have flutter, which I could present here.

Fibrillation, when it is disturbing the patient, might be also an indication to try catheter ablation, but when it is with a normal heart rate, it is not.

Patients with hypoplastic left heart syndrome were excluded, and they were not amenable for this type of Fontan operation. And we could not see a difference at present between the patients with TrA and the other patient group with regard to the success rate or ablation rate. The patient numbers are too small, and the numbers of failures are too small also. Atrial fibrillation alone is not an indication to convert the Fontan tunnel to a total cavapulmonary anastomosis.

Dr Marcus Haw (Southampton, United Kingdom). I come from a center from which Dr Batts published his results with ablation, and therefore we congratulate you with your fantastic results for transcatheter intervention.

We followed very much Dr Mavroudis' line in treating these patients, and we have almost invariably found with the traditional type of atriopulmonary connection that patients have a good deal of effort intolerance, as well as the intermittent flutter, and I wonder if you have any sort of outcome data in terms of your patients' functional status after a successful ablation?

Dr Weipert. The follow-up is short, and we do not have functional data at present. Patients were satisfied with their clinical condition when atrial flutter could be abolished or arrhythmia frequency decreased. But we do not have objective methods where we can say it is really an advantage for this patient.

Dr Haw. Thank you.

Dr Thomas L. Spray (Philadelphia, Pa). How many of these patients in late follow-up ended up with a pacemaker, and how many are still receiving antiarrhythmia medications?

Dr Weipert. Three patients ended up with a pacemaker, and 3 of them are taking amiodarone.

Dr Spray. And are they all receiving ß-blockers or only a selected portion?

Dr Weipert. Most of the patients are receiving ß-blockers.

Dr Carlos Troconis (Caracas, Venezuela). Are those arrhythmias surgically related, or were they related to dilatation of the right atrium?

The reason for my question is because in the past 5 years, we have operated on 3 patients older than 18 years with extracardiac conduit, and all of them had normal sinus rhythm at follow-up. On the other hand, we have 20 cases (2-4 years of age at operation) over 10 years' follow-up of extracardiac conduit, and we have not seen any surgically related arrhythmias at all.

Dr Weipert. The lateral tunnel Fontan operation might be very promising for the future.

There was a recent article from the Boston group: at 10 years, 90% of the patients with a lateral tunnel were free from new supraventricular tachycardias. The lateral tunnel approach probably is the best solution for the univentricular heart at present.

In the patient with a failing Fontan operation, when there are surgically amenable lesions, we go ahead and make a conversion, but in these patients this was not the case.

	Footnotes

 
^* Gore-Tex, registered trademark of W. L. Gore & Associates, Inc, Newark, Del.

	References

Top Abstract Methods Results Discussion References

 

1. Fontan F, Kirklin JW, Fernandes G. Outcome after a perfect Fontan operation. Circulation. 1990;81:1520–1536[Abstract/Free Full Text]
   
2. Driscoll DJ, Offord KP, Feldt DF, Schaff H, Puga FJ, Danielson G. Five- to fifteen-year follow-up after Fontan operation. Circulation. 1992;85:469–496[Abstract/Free Full Text]
   
3. Mertens L, Hagler AJ, Sauer U, Somerville J, Gewillig M. Protein-losing enteropathy after the Fontan operation: an international multicenter study. J Thorac Cardiovasc Surg. 1998;115:1063–1073[Abstract/Free Full Text]
   
4. Balling G, Vogt M, Kaemmerer H, Eicken A, Meisner H, Hess J. Intracardiac thrombus formation after the Fontan operation. J Thorac Cardiovasc Surg. 2000;119:745–752[Abstract/Free Full Text]
   
5. Fishberger SB, Wernovsky G, Gentles TL, Gauvreau K, Burnett J, Mayer JE, et al. Factors that influence the development of atrial flutter after the Fontan operation. J Thorac Cardiovasc Surg. 1997;113:80–86[Abstract/Free Full Text]
   
6. Durongpisitkul K, Porter CJ, Cetta F, Offord KP, Slezak JM, Puga FJ, et al. Predictors of early- and late-onset supraventricular tachyarrhythmias after Fontan operation. Circulation. 1998;98:1099–1107[Abstract/Free Full Text]
   
7. Gentles TL, Gauvreau K, Mayer JE Jr, Fishberger SB, Burnett J, Colan SD, et al. Functional outcome after the Fontan operation: factors influencing late morbidity. J Thorac Cardiovasc Surg. 1997;114:392–403[Abstract/Free Full Text]
   
8. Gentles TL, Mayer JE Jr, Gauvreau K, Newburger JW, Lock JE, Kupferschmid JP, et al. Fontan operation in five hundred consecutive patients: factors influencing early and late outcome. J Thorac Cardiovasc Surg. 1997;114:376–391[Abstract/Free Full Text]
   
9. Triedmann JK, Bergau DM, Saul JP, Epstein MR, Walsh EP. Efficacy of radiofrequency ablation for control of intraatrial reentrant tachycardia in patients with congenital heart disease. J Am Coll Cardiol. 1997;30:1032–1038[Abstract]
   
10. Betts TR, Roberts PR, Allen SA, Salmon AP, Keeton BR, Haw MP, et al. Electrophysiological mapping and ablation of intra-atrial reentry tachycardia after Fontan surgery with the use of a noncontact mapping system. Circulation. 2000;102:419–425[Abstract/Free Full Text]
    
11. Deal BJ, Mavroudis C, Backer CL, Buck SH, Jonsrude C. Comparison of anatomic isthmus block with the modified right atrial maze procedure for late atrial tachycardia in Fontan patients. Circulation. 2002;106:575–579[Abstract/Free Full Text]
    
12. Mavroudis C, Backer CL, Deal BJ, Johnsrude CL. Fontan conversion to cavopulmonary connection and arrhythmia circuit cryoablation. J Thorac Cardiovasc Surg. 1998;115:547–556[Abstract/Free Full Text]
    
13. Mavroudis C, Backer CL, Deal BJ, Johnsrude CL. Total cavopulmonary conversion and maze procedure for patients with failure of the Fontan operation. J Thorac Cardiovasc Surg. 2001;122:863–871[Abstract/Free Full Text]
    
14. Stamm S, Friehs I, Mayer JE, Zurakowski D, Triedmann JK, Moran AM, et al. Long-term results of the lateral tunnel Fontan operation. J Thorac Cardiovasc Surg. 2001;121:28–41
    
15. Schmitt C, Zrenner B, Schneider M, Karch MR, Ndrepepa G, Deisenhofer I, et al. Clinical experience with a novel multielectrode basket catheter in right atrial tachycardias. Circulation. 1999;99:2414–2422[Abstract/Free Full Text]
    
16. Zrenner B, Ndrepepa G, Schneider M, Karch MR, Hofmann F, Schoemig A, et al. Computer assisted animation of atrial tachycardias recorded with a 64-electrode basket catheter. J Am Coll Cardiol. 1999;34:2051–2060[Abstract/Free Full Text]
    
17. Bjoerk V, Olin CL, Bjarke BB, Thoren CA. Right atrial-right ventricular anastomosis for correction of tricuspid atresia. J Thorac Cardiovasc Surg. 1979;77:452–458[Abstract]
    
18. Kreutzer G, Galindez E, Bono H, de Palma C, Laura JP. An operation for the correction of tricuspid atresia. J Thorac Cardiovasc Surg. 1973;66:105–111[Medline]
    
19. Weipert J, Koch W, Haehnel JC, Meisner H. Exercise capacity and mid-term survival after in patients with tricuspid atresia and complex congenital cardiac malformation modified Fontan-operation. Eur J Cardiothorac Surg. 1997;12:574–580[Abstract]
    
20. Knott-Craig CJ, Danielson GK, Schaff H, Puga F, Weaver A, Driscoll D. The modified Fontan operation. An analysis of risk factors for early postoperative death or takedown in 702 consecutive patients from one institution. J Thorac Cardiovasc Surg. 1995;109(6):1237–1243
    
21. Fontan F, Baudet E. Surgical repair of tricuspid atresia. Thorax. 1971;26:240–248[Medline]
    
22. Chan DP, van Hare GF, Mackall JA, Carlson MD, Waldo AL. Importance of atrial flutter isthmus in postoperative intra-atrial reentrant tachycardia. Circulation. 2000;102:1283–1289[Abstract/Free Full Text]
    
23. Zrenner B, Ndrepepa G, Schneider M, Karch MR, Brodherr-Heberlin S, Kaemmerer H, et al. Mapping and ablation of atrial arrhythmias after surgical correction of congenital heart disease guided by a 64-electrode basket catheter. Am J Cardiol. 2001;88:573–578[Medline]
    

This article has been cited by other articles:

				S.-J. Kim, W.-H. Kim, H.-G. Lim, and J.-Y. Lee Outcome of 200 patients after an extracardiac Fontan procedure J. Thorac. Cardiovasc. Surg., July 1, 2008; 136(1): 108 - 116. [Abstract] [Full Text] [PDF]

				N. Anand, B. W. McCrindle, C. C. Chiu, R. M. Hamilton, J. A. Kirsh, E. A. Stephenson, and G. J. Gross Chronotropic incompetence in young patients with late postoperative atrial flutter: a case-control study Eur. Heart J., September 1, 2006; 27(17): 2069 - 2073. [Abstract] [Full Text] [PDF]

				S. Giannico, F. Hammad, A. Amodeo, G. Michielon, F. Drago, A. Turchetta, R. Di Donato, and S. P. Sanders Clinical Outcome of 193 Extracardiac Fontan Patients: The First 15 Years J. Am. Coll. Cardiol., May 16, 2006; 47(10): 2065 - 2073. [Abstract] [Full Text] [PDF]

				M. N. Kavarana, S. Pagni, M. R. Recto, W. L. Sobczyk, T. Yeh Jr, M. Mitchell, and E. H. Austin III Seven-Year Clinical Experience With the Extracardiac Pedicled Pericardial Fontan Operation Ann. Thorac. Surg., July 1, 2005; 80(1): 37 - 43. [Abstract] [Full Text] [PDF]

				A. T. Lovell Anaesthetic implications of grown-up congenital heart disease Br. J. Anaesth., July 1, 2004; 93(1): 129 - 139. [Abstract] [Full Text] [PDF]

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Joachim Weipert Christian Schreiber Martin Kostolny Ruediger Lange Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Weipert, J. Articles by Lange, R. Search for Related Content PubMed PubMed Citation Articles by Weipert, J. Articles by Lange, R. Related Collections Electrophysiology - arrhythmias